March 17, 2022
UC San Diego study shows neuroendocrine cells in the lungs drive a developmental lung disease, and a similar brain-lung interaction may contribute to COVID-19 symptoms. The findings suggest neuropeptides may be a promising therapeutic target for conditions with excess lung fluid.
May 1, 2015
Synthetic microscopic beads sense changes in their environment and self-propel to migrate upstream, a step toward the realization of biomimetic microsystems with the ability to sense and respond to environmental changes.
January 8, 2018
Jacobs Medical Center at UC San Diego Health in La Jolla recently received certification from the Joint Commission to be a Comprehensive Stroke Center. This certification is in addition to the existing accreditation at UC San Diego Medical Center in Hillcrest. This expansion makes UC San Diego Health the only…
September 26, 2024
Patient undergoes 5,000th innovative surgery by a multidisciplinary team at UC San Diego Health to remove blood clots from the lung’s paper-thin arteries.
March 7, 2023
UC San Diego researchers delve deep into the unknown cause of pediatric acute myeloid leukemia to identify a gene splicing dysregulation and potential target for treating the disease, which often becomes treatment-resistant.
September 29, 2020
Networking California for Sickle Cell Care Initiative supports expansion of San Diego’s only adult sickle cell disease clinic at UC San Diego Health which offers child-to-adult transition health services to patients like Vanessa Hughes.
March 11, 2014
Three weeks after delivering her first child, Amanda began to suffer from extreme fatigue, headaches, a tight chest and stomach pain. An initial diagnosis of pneumonia changed for the worse: Amanda was experiencing heart failure. She was quickly transferred to UC San Diego Sulpizio Cardiovascular Center where a multidisciplinary team…
October 5, 2011
…process in which proteins, lipids and DNA damaged by oxygen free radicals and related cellular waste accumulate, prompting an inflammatory response from the body’s innate immune system that results in chronic disease.
February 6, 2017
In a mouse study, researchers at University of California San Diego School of Medicine have identified a protein that inhibits the enzyme that breaks down bilirubin in newborns. Methods that block this inhibitor, and thus restore the enzyme’s activity, could provide a new therapeutic approach for preventing or treating severe…
March 25, 2019
Three researchers at the University of California, San Diego were inducted into the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE), the organization announced.
